Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000950123-04-012137
Filing Date
2004-10-18
Accepted
2004-10-18 10:25:39
Documents
1
Effectiveness Date
2004-10-18

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS y67690dfan14a.txt DFAN14A 7344
  Complete submission text file 0000950123-04-012137.txt   9365
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Subject) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: DFAN14A | Act: 34 | File No.: 001-12493 | Film No.: 041082424
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 225 E DEERPATH RD STE 250 LAKE FOREST IL 60045
Business Address 225 EAST DEERPATH RD SUITE 250 LAKE FOREST IL 60045 7704429707
KAPOOR JOHN N (Filed by) CIK: 0001033150 (see all company filings)